Novartis Maintains Beovu Eye Inflammation Rates Low, Defending Safety of New Drug
Novartis says that rates of eye inflammation and vision loss linked to Beovu are below those listed on the warning label.…
«
»
Novartis says that rates of eye inflammation and vision loss linked to Beovu are below those listed on the warning label.…
A group of retinal specialists warn that the eye treatment Beovu has been linked to cases of eye inflammation which could result in vision loss.…
Tasigna is a blockbuster cancer drug used to treat chronic myeloid leukemia (CML), which has been linked to serious side effects that can constrict and harden arteries, potentially increasing the risk of heart attack, stroke, amputation and sudden death. …
All generic Zantac manufactured and distributed by Sandoz has been recalled due to NDMA contamination.…
The heartburn drug Zantac is being pulled from the market after a pharmacy found that it contained large amounts of a likely cancer-causing impurity.…
The FDA says a Novartis subsidiary manipulated data in animal trials used to approve a gene therapy treatment for children, but will let the treatment, the most expensive in the world, stay on the market due to a lack of other treatment options.…
Novartis has filed a lawsuit against Johnson & Johnson claiming it is using misleading advertising to promote the psoriasis drug Tremfya, which omits critical safety data.…
In response to growing concerns about the safety of generic drugs, which emerged following recent valsartan recalls issued over cancer-causing impurities, federal regulators are defending their oversight and monitoring of generic manufacturers.…
Cancer-causing impurities found in recalled valsartan may have been the result of a process that sought to make more of the hypertension drug at a faster pace.…
A leading cancer researcher who failed to reveal deep industry ties and millions in payments has been ousted from a leading cancer center and sparked debate about the need for full financial disclosures in scientific research.…